Correction to “Impact analysis of heart failure across European countries: an ESC‐HFA position paper” and “Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan”

. 2024 Jan 11;11(2):1280. doi: 10.1002/ehf2.14672

PMCID: PMC10966236 PMID: 38211306

Massimo Piepoli's affiliations was incorrect.

It should have read:

Department of Biomedical Science for Health, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy
Clinical Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy

The affected articles are listed in the reference list. ¹ , ²

We apologize for these errors.

References

1. Rosano GMC, Seferovic P, Savarese G, Spoletini I, Lopatin Y, Gustafsson F, et al. Impact analysis of heart failure across European countries: An ESC‐HFA position paper. ESC Heart Fail 2022;9:2767‐2778. doi: 10.1002/ehf2.14076 [DOI] [PMC free article] [PubMed] [Google Scholar]
2. Dini FL, Carluccio E, Bitto R, Ciccarelli M, Correale M, D'Agostino A, et al. Working Group on Heart Failure of the Italian Society of Cardiology. Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan. ESC Heart Fail 2022;9:1107‐1117. doi: 10.1002/ehf2.13779 [DOI] [PMC free article] [PubMed] [Google Scholar]